Work

A Phase I/II Study of Chemosensitization with the CXCR4 Antagonist Plerixafor in Relapsed or Refractory AML.

Year: 2009

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v114.22.787.787

Authors: Geoffrey L. Uy, Michael P. Rettig, Kyle McFarland, Lindsay Hladnik, Shashikant Kulkarni, Camille N. Abboud, Amanda F Cashen, Keith Stockerl-Goldstein, Ravi Vij, Peter Westervelt, John F. DiPersio

Institution: Washington University in St. Louis

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2977357338

FWCI: 1.753

Cites:

Cited by: 9

Related to: 10